Rezultati

eNauka >  Results >  Efficacy and safety of melflufen plus daratumumab and dexamethasone in relapsed/refractory multiple myeloma: results from the randomized, open-label, phase III LIGHTHOUSE study
Title: Efficacy and safety of melflufen plus daratumumab and dexamethasone in relapsed/refractory multiple myeloma: results from the randomized, open-label, phase III LIGHTHOUSE study
Authors : Pour, Ludek; ...; Bila, Jelena S.  ; ...; (broj koautora 16)
Issue Date: 2024
Publication: Haematologica
ISSN: 0390-6078 Haematologica Search Idenfier
Publisher: Pavia, Italy : Ferrata Storti Foundation
Type: Article
Collation: vol. 109 br. 3 str. 895-905
DOI: 10.3324/haematol.2023.283509
WoS-ID: 001182209400032
Scopus-ID: 2-s2.0-85186504971
PMID: 37646660
PMCID: PMC10905085
URI: https://enauka.gov.rs/handle/123456789/937350
URL: https://haematologica.org/article/view/haematol.2023.283509
Project: [NCT04649060]
Metadata source: (Preuzeto iz Nasi u WoS)
M-category: 
21aM21a

12
SCOPUSTM
7
PubMed CentralTM
14
WEB OF SCIENCETM
Alt metrika
Dimensions
Unpaywall

Rezultati na eNauka su zaštićeni autorskim pravima i sva prava su zadržana, osim ako nije drugačije naznačeno.